| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sphingosine | 105 | 2024 | 308 | 19.210 |
Why?
|
| Lysophospholipids | 98 | 2024 | 339 | 18.580 |
Why?
|
| Receptors, Lysosphingolipid | 63 | 2024 | 121 | 12.280 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 41 | 2007 | 318 | 4.020 |
Why?
|
| Endothelium, Vascular | 46 | 2023 | 4437 | 3.250 |
Why?
|
| Receptors, G-Protein-Coupled | 36 | 2023 | 1244 | 3.190 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 20 | 2020 | 436 | 2.720 |
Why?
|
| Sphingolipids | 13 | 2024 | 173 | 2.680 |
Why?
|
| Endothelial Cells | 32 | 2024 | 3537 | 2.530 |
Why?
|
| Receptors, Lysophospholipid | 32 | 2020 | 40 | 2.380 |
Why?
|
| Propylene Glycols | 16 | 2015 | 90 | 2.200 |
Why?
|
| Isoenzymes | 28 | 2008 | 1690 | 2.120 |
Why?
|
| Neovascularization, Physiologic | 15 | 2020 | 1335 | 2.000 |
Why?
|
| Signal Transduction | 79 | 2024 | 23363 | 1.920 |
Why?
|
| Immediate-Early Proteins | 19 | 2008 | 449 | 1.760 |
Why?
|
| Cyclooxygenase 2 | 32 | 2010 | 600 | 1.710 |
Why?
|
| Neovascularization, Pathologic | 18 | 2020 | 2641 | 1.700 |
Why?
|
| Receptors, Cell Surface | 28 | 2003 | 2825 | 1.620 |
Why?
|
| Apolipoproteins | 5 | 2024 | 320 | 1.510 |
Why?
|
| Capillary Permeability | 11 | 2024 | 768 | 1.510 |
Why?
|
| Lipoproteins, HDL | 6 | 2024 | 667 | 1.220 |
Why?
|
| Animals | 182 | 2024 | 167940 | 1.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 16 | 2022 | 3483 | 1.150 |
Why?
|
| Mice | 113 | 2024 | 81216 | 1.090 |
Why?
|
| Cardiovascular System | 9 | 2020 | 850 | 1.060 |
Why?
|
| Lipocalins | 3 | 2024 | 161 | 1.000 |
Why?
|
| Inflammation | 22 | 2024 | 10757 | 0.970 |
Why?
|
| Mammary Neoplasms, Experimental | 8 | 2013 | 501 | 0.960 |
Why?
|
| Gene Expression Regulation, Enzymologic | 13 | 2010 | 1173 | 0.930 |
Why?
|
| Adherens Junctions | 6 | 2022 | 89 | 0.930 |
Why?
|
| Homeostasis | 9 | 2024 | 3305 | 0.920 |
Why?
|
| Blood Vessels | 9 | 2016 | 1112 | 0.870 |
Why?
|
| I-kappa B Proteins | 6 | 2001 | 212 | 0.840 |
Why?
|
| Serine C-Palmitoyltransferase | 1 | 2022 | 42 | 0.830 |
Why?
|
| Receptors, Lysophosphatidic Acid | 6 | 2020 | 77 | 0.820 |
Why?
|
| Ceramides | 3 | 2022 | 200 | 0.760 |
Why?
|
| Mice, Knockout | 34 | 2024 | 14396 | 0.750 |
Why?
|
| Cell Movement | 25 | 2019 | 5206 | 0.740 |
Why?
|
| GTP-Binding Proteins | 13 | 2009 | 951 | 0.710 |
Why?
|
| Retinal Neovascularization | 1 | 2023 | 273 | 0.700 |
Why?
|
| Immunosuppressive Agents | 12 | 2017 | 4168 | 0.700 |
Why?
|
| Endothelium, Lymphatic | 1 | 2020 | 63 | 0.690 |
Why?
|
| Cells, Cultured | 50 | 2022 | 18968 | 0.680 |
Why?
|
| Macrophages | 10 | 2019 | 5745 | 0.670 |
Why?
|
| Mammary Glands, Animal | 5 | 2013 | 265 | 0.670 |
Why?
|
| Apolipoproteins A | 1 | 2019 | 95 | 0.660 |
Why?
|
| Chemotaxis | 6 | 2009 | 598 | 0.650 |
Why?
|
| Cadherins | 6 | 2024 | 898 | 0.650 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 116 | 0.640 |
Why?
|
| RNA, Messenger | 42 | 2019 | 12762 | 0.630 |
Why?
|
| Conservation of Natural Resources | 1 | 2021 | 211 | 0.630 |
Why?
|
| Transcription Factor AP-1 | 1 | 2020 | 321 | 0.620 |
Why?
|
| PPAR delta | 2 | 2008 | 40 | 0.610 |
Why?
|
| MicroRNAs | 5 | 2015 | 3784 | 0.610 |
Why?
|
| RNA-Binding Proteins | 6 | 2011 | 1892 | 0.610 |
Why?
|
| Receptors, Prostaglandin E | 4 | 2007 | 56 | 0.610 |
Why?
|
| Leukotriene B4 | 2 | 2018 | 281 | 0.600 |
Why?
|
| Interleukin-1 | 9 | 1999 | 1250 | 0.580 |
Why?
|
| Cyclooxygenase Inhibitors | 6 | 2005 | 364 | 0.570 |
Why?
|
| Muscle, Smooth, Vascular | 10 | 2009 | 1484 | 0.560 |
Why?
|
| Central Nervous System | 4 | 2019 | 1334 | 0.560 |
Why?
|
| Blood-Brain Barrier | 3 | 2020 | 1017 | 0.550 |
Why?
|
| Endocytosis | 6 | 2017 | 960 | 0.540 |
Why?
|
| Serum Albumin | 1 | 2019 | 674 | 0.530 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2020 | 3601 | 0.530 |
Why?
|
| Atherosclerosis | 8 | 2024 | 3524 | 0.500 |
Why?
|
| Rheumatic Diseases | 1 | 2022 | 639 | 0.500 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2014 | 6 | 0.500 |
Why?
|
| Antigens, Surface | 4 | 2009 | 1616 | 0.490 |
Why?
|
| Gene Expression Regulation | 14 | 2021 | 11902 | 0.490 |
Why?
|
| Macrophages, Peritoneal | 2 | 2013 | 237 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 26 | 2022 | 22025 | 0.480 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 9 | 2002 | 854 | 0.480 |
Why?
|
| Lymphopoiesis | 1 | 2015 | 133 | 0.470 |
Why?
|
| Lymphocytes | 3 | 2015 | 2612 | 0.470 |
Why?
|
| Retinal Vessels | 1 | 2020 | 836 | 0.460 |
Why?
|
| Fibroblast Growth Factor 1 | 7 | 2007 | 56 | 0.420 |
Why?
|
| Phosphoric Monoester Hydrolases | 4 | 2012 | 414 | 0.420 |
Why?
|
| Humans | 171 | 2024 | 760261 | 0.410 |
Why?
|
| Arthritis, Experimental | 6 | 2024 | 292 | 0.410 |
Why?
|
| Chemotaxis, Leukocyte | 3 | 2010 | 663 | 0.410 |
Why?
|
| Base Sequence | 24 | 2014 | 12447 | 0.410 |
Why?
|
| Pulmonary Edema | 3 | 2011 | 409 | 0.410 |
Why?
|
| Synovial Membrane | 9 | 2006 | 524 | 0.410 |
Why?
|
| Membrane Proteins | 27 | 2024 | 7854 | 0.410 |
Why?
|
| Multiple Sclerosis | 5 | 2022 | 3202 | 0.410 |
Why?
|
| Prostaglandins | 10 | 2008 | 398 | 0.400 |
Why?
|
| Aorta | 2 | 2020 | 2042 | 0.400 |
Why?
|
| Cell Line | 30 | 2021 | 15626 | 0.400 |
Why?
|
| Aldehyde-Lyases | 3 | 2008 | 13 | 0.400 |
Why?
|
| Molecular Sequence Data | 25 | 2014 | 17628 | 0.400 |
Why?
|
| Lymph Nodes | 4 | 2019 | 3491 | 0.390 |
Why?
|
| rho GTP-Binding Proteins | 5 | 2022 | 277 | 0.390 |
Why?
|
| Autoimmune Diseases | 5 | 2019 | 2250 | 0.390 |
Why?
|
| Cell Membrane | 7 | 2019 | 3683 | 0.390 |
Why?
|
| Capillary Leak Syndrome | 1 | 2011 | 32 | 0.380 |
Why?
|
| RNA, Small Interfering | 7 | 2010 | 3443 | 0.380 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2019 | 414 | 0.380 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 4 | 2019 | 825 | 0.380 |
Why?
|
| Vasculitis | 1 | 2015 | 523 | 0.370 |
Why?
|
| Bone Marrow Cells | 2 | 2009 | 2424 | 0.370 |
Why?
|
| Models, Biological | 13 | 2019 | 9468 | 0.370 |
Why?
|
| Thrombopoiesis | 1 | 2012 | 164 | 0.370 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2020 | 2874 | 0.370 |
Why?
|
| Students | 1 | 2021 | 1722 | 0.370 |
Why?
|
| Reperfusion Injury | 1 | 2017 | 1023 | 0.360 |
Why?
|
| Fibrosis | 6 | 2021 | 2042 | 0.360 |
Why?
|
| Glucose Intolerance | 1 | 2014 | 579 | 0.360 |
Why?
|
| Ligands | 13 | 2020 | 3277 | 0.350 |
Why?
|
| Cell Migration Inhibition | 1 | 2009 | 97 | 0.350 |
Why?
|
| Vertebrates | 2 | 2008 | 228 | 0.340 |
Why?
|
| rhoA GTP-Binding Protein | 4 | 2021 | 235 | 0.340 |
Why?
|
| Dinoprostone | 10 | 2007 | 599 | 0.340 |
Why?
|
| Alternative Splicing | 1 | 2014 | 1091 | 0.330 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2022 | 2160 | 0.330 |
Why?
|
| Transfection | 15 | 2007 | 5782 | 0.330 |
Why?
|
| Amino Acid Sequence | 19 | 2019 | 13456 | 0.330 |
Why?
|
| Zebrafish | 8 | 2019 | 2996 | 0.330 |
Why?
|
| Chemokine CCL5 | 1 | 2009 | 214 | 0.330 |
Why?
|
| Neoplasms | 8 | 2021 | 22066 | 0.330 |
Why?
|
| Mice, Transgenic | 16 | 2022 | 9531 | 0.330 |
Why?
|
| Lipoproteins, LDL | 3 | 2019 | 641 | 0.320 |
Why?
|
| Biological Transport | 5 | 2017 | 2087 | 0.320 |
Why?
|
| HEK293 Cells | 8 | 2019 | 4264 | 0.320 |
Why?
|
| Erythrocytes | 2 | 2016 | 2415 | 0.320 |
Why?
|
| Intercellular Junctions | 2 | 1999 | 197 | 0.310 |
Why?
|
| Protein Phosphatase 2 | 1 | 2010 | 236 | 0.310 |
Why?
|
| Prostaglandin D2 | 5 | 2001 | 110 | 0.310 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 1387 | 0.300 |
Why?
|
| Arthritis, Rheumatoid | 11 | 2024 | 3763 | 0.300 |
Why?
|
| Zebrafish Proteins | 3 | 2014 | 1006 | 0.300 |
Why?
|
| Peritonitis | 1 | 2009 | 370 | 0.290 |
Why?
|
| Phosphorylation | 14 | 2013 | 8314 | 0.290 |
Why?
|
| Disease Models, Animal | 17 | 2021 | 18134 | 0.290 |
Why?
|
| Inflammation Mediators | 4 | 2023 | 1882 | 0.290 |
Why?
|
| DNA Primers | 10 | 2006 | 2819 | 0.280 |
Why?
|
| Cell Proliferation | 12 | 2020 | 10434 | 0.280 |
Why?
|
| Down-Regulation | 4 | 2014 | 2918 | 0.280 |
Why?
|
| Blood Coagulation | 2 | 2022 | 1156 | 0.280 |
Why?
|
| rho-Associated Kinases | 5 | 2017 | 281 | 0.280 |
Why?
|
| Tetradecanoylphorbol Acetate | 8 | 2006 | 819 | 0.270 |
Why?
|
| Endocannabinoids | 1 | 2007 | 111 | 0.270 |
Why?
|
| Chromatography, Affinity | 1 | 2007 | 534 | 0.270 |
Why?
|
| Umbilical Veins | 10 | 2003 | 426 | 0.270 |
Why?
|
| Kinetics | 14 | 2010 | 6378 | 0.260 |
Why?
|
| Biochemistry | 1 | 2006 | 114 | 0.260 |
Why?
|
| Blood Platelets | 2 | 2016 | 2522 | 0.260 |
Why?
|
| Enzyme Inhibitors | 5 | 2010 | 3726 | 0.260 |
Why?
|
| Metabolic Diseases | 1 | 2012 | 685 | 0.260 |
Why?
|
| Adenomatous Polyps | 1 | 2006 | 108 | 0.260 |
Why?
|
| Thromboplastin | 1 | 2007 | 286 | 0.260 |
Why?
|
| T-Lymphocytes | 4 | 2017 | 10183 | 0.250 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 685 | 0.250 |
Why?
|
| Aromatase | 4 | 2013 | 147 | 0.250 |
Why?
|
| Lung | 9 | 2022 | 9989 | 0.250 |
Why?
|
| Autophagy | 1 | 2013 | 1336 | 0.250 |
Why?
|
| Ferric Compounds | 1 | 2007 | 378 | 0.250 |
Why?
|
| Transcription, Genetic | 13 | 2007 | 7593 | 0.250 |
Why?
|
| Extracellular Fluid | 2 | 2019 | 165 | 0.250 |
Why?
|
| Neuroblastoma | 4 | 2015 | 1252 | 0.250 |
Why?
|
| Green Fluorescent Proteins | 5 | 2020 | 2056 | 0.250 |
Why?
|
| Prostaglandins, Synthetic | 1 | 2004 | 24 | 0.240 |
Why?
|
| Protein Binding | 11 | 2019 | 9336 | 0.240 |
Why?
|
| Gene Deletion | 5 | 2022 | 2668 | 0.240 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2008 | 1115 | 0.240 |
Why?
|
| Dietary Supplements | 1 | 2017 | 3389 | 0.240 |
Why?
|
| Enzyme Activation | 10 | 2017 | 3604 | 0.240 |
Why?
|
| Apoptosis | 11 | 2015 | 9497 | 0.240 |
Why?
|
| Aortic Diseases | 1 | 2010 | 736 | 0.240 |
Why?
|
| Cloning, Molecular | 9 | 2012 | 4172 | 0.240 |
Why?
|
| Extremities | 2 | 2014 | 867 | 0.230 |
Why?
|
| Catenins | 1 | 2024 | 41 | 0.230 |
Why?
|
| Animal Structures | 1 | 2004 | 24 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 8 | 2014 | 3735 | 0.230 |
Why?
|
| Morphogenesis | 4 | 2020 | 740 | 0.220 |
Why?
|
| Hypertension | 3 | 2021 | 8595 | 0.220 |
Why?
|
| Lipids | 4 | 2010 | 3336 | 0.220 |
Why?
|
| DNA-Binding Proteins | 7 | 2014 | 9590 | 0.220 |
Why?
|
| Xenopus | 4 | 2001 | 717 | 0.220 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2003 | 617 | 0.220 |
Why?
|
| Regeneration | 2 | 2024 | 1506 | 0.220 |
Why?
|
| 3' Untranslated Regions | 3 | 2014 | 514 | 0.220 |
Why?
|
| Anion Transport Proteins | 2 | 2021 | 141 | 0.220 |
Why?
|
| Cell Differentiation | 10 | 2014 | 11480 | 0.220 |
Why?
|
| Cyclooxygenase 1 | 8 | 2004 | 98 | 0.210 |
Why?
|
| Genes, Immediate-Early | 3 | 1998 | 101 | 0.210 |
Why?
|
| Second Messenger Systems | 2 | 2004 | 202 | 0.210 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2005 | 459 | 0.210 |
Why?
|
| rac GTP-Binding Proteins | 4 | 2009 | 162 | 0.210 |
Why?
|
| Nitric Oxide Synthase Type III | 4 | 2017 | 704 | 0.210 |
Why?
|
| Ubiquitin | 2 | 2007 | 840 | 0.210 |
Why?
|
| Intestinal Mucosa | 4 | 2018 | 3023 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2014 | 8498 | 0.210 |
Why?
|
| Foam Cells | 2 | 2019 | 68 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2017 | 3451 | 0.200 |
Why?
|
| Cardiovascular Physiological Phenomena | 2 | 2019 | 239 | 0.200 |
Why?
|
| rac1 GTP-Binding Protein | 3 | 2021 | 242 | 0.200 |
Why?
|
| Karyopherins | 1 | 2002 | 130 | 0.200 |
Why?
|
| Fibroblasts | 8 | 2024 | 4091 | 0.200 |
Why?
|
| Cell Adhesion | 4 | 2014 | 3096 | 0.200 |
Why?
|
| Computer Communication Networks | 1 | 2004 | 294 | 0.200 |
Why?
|
| Receptors, Growth Factor | 2 | 2001 | 326 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2011 | 1246 | 0.200 |
Why?
|
| Cell Survival | 8 | 2017 | 5796 | 0.200 |
Why?
|
| Imidazoles | 2 | 2005 | 1178 | 0.190 |
Why?
|
| Wilms Tumor | 3 | 2009 | 376 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2015 | 3390 | 0.190 |
Why?
|
| Vascular Diseases | 2 | 2009 | 1180 | 0.190 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 3613 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2019 | 2473 | 0.190 |
Why?
|
| Dactinomycin | 7 | 2000 | 306 | 0.190 |
Why?
|
| Myanmar | 1 | 2021 | 44 | 0.190 |
Why?
|
| Molecular Chaperones | 2 | 2019 | 752 | 0.190 |
Why?
|
| Publications | 1 | 2004 | 194 | 0.190 |
Why?
|
| Cardiovascular Diseases | 5 | 2020 | 15740 | 0.190 |
Why?
|
| Antigens, CD | 5 | 2024 | 4002 | 0.190 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 250 | 0.190 |
Why?
|
| Transcription Factors | 10 | 2020 | 12100 | 0.190 |
Why?
|
| Retinal Diseases | 1 | 2007 | 702 | 0.190 |
Why?
|
| Eicosanoids | 2 | 2018 | 278 | 0.190 |
Why?
|
| Receptors, Vitronectin | 1 | 2001 | 48 | 0.190 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 5 | 2007 | 321 | 0.180 |
Why?
|
| Cell Division | 10 | 2004 | 4462 | 0.180 |
Why?
|
| Gene Silencing | 2 | 2005 | 1511 | 0.180 |
Why?
|
| Lymphoid Tissue | 2 | 2017 | 446 | 0.180 |
Why?
|
| NF-kappa B | 4 | 2015 | 2486 | 0.180 |
Why?
|
| Thiazolidinediones | 5 | 2002 | 465 | 0.180 |
Why?
|
| Mutant Proteins | 2 | 2014 | 492 | 0.180 |
Why?
|
| Insulin Resistance | 1 | 2014 | 3960 | 0.180 |
Why?
|
| Up-Regulation | 4 | 2019 | 4127 | 0.180 |
Why?
|
| Chemokine CXCL12 | 2 | 2012 | 454 | 0.180 |
Why?
|
| Colitis, Ulcerative | 1 | 2013 | 1919 | 0.180 |
Why?
|
| Fatty Acids, Unsaturated | 2 | 2003 | 542 | 0.180 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2007 | 1314 | 0.180 |
Why?
|
| Mice, Nude | 7 | 2015 | 3605 | 0.180 |
Why?
|
| Erythropoiesis | 2 | 2014 | 682 | 0.180 |
Why?
|
| Immune System Phenomena | 1 | 2019 | 17 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor C | 1 | 2020 | 127 | 0.170 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 1 | 2020 | 119 | 0.170 |
Why?
|
| Lipid Metabolism | 3 | 2024 | 1902 | 0.170 |
Why?
|
| Chloride Channels | 1 | 2021 | 221 | 0.170 |
Why?
|
| Pulmonary Fibrosis | 1 | 2024 | 507 | 0.170 |
Why?
|
| Tumor Cells, Cultured | 9 | 2014 | 6131 | 0.170 |
Why?
|
| RNA Interference | 2 | 2008 | 2846 | 0.170 |
Why?
|
| Edema | 1 | 2023 | 772 | 0.170 |
Why?
|
| Drosophila Proteins | 1 | 2009 | 1699 | 0.170 |
Why?
|
| Pyrazoles | 6 | 2015 | 1992 | 0.170 |
Why?
|
| Protein Transport | 7 | 2009 | 1966 | 0.160 |
Why?
|
| Shock | 1 | 2021 | 318 | 0.160 |
Why?
|
| Thiophenes | 4 | 2018 | 587 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13629 | 0.160 |
Why?
|
| Gene Knockout Techniques | 2 | 2019 | 803 | 0.160 |
Why?
|
| Lymphangiogenesis | 1 | 2020 | 172 | 0.160 |
Why?
|
| Xenopus Proteins | 1 | 2001 | 434 | 0.160 |
Why?
|
| Galactosylceramides | 1 | 2019 | 92 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2006 | 951 | 0.160 |
Why?
|
| Serine | 1 | 2022 | 831 | 0.160 |
Why?
|
| Lymphopenia | 2 | 2011 | 280 | 0.160 |
Why?
|
| Cell Communication | 2 | 2020 | 1642 | 0.160 |
Why?
|
| Bleomycin | 2 | 2022 | 496 | 0.160 |
Why?
|
| Blotting, Western | 11 | 2014 | 5039 | 0.160 |
Why?
|
| Acetaminophen | 1 | 2022 | 553 | 0.150 |
Why?
|
| Heart | 5 | 2024 | 4392 | 0.150 |
Why?
|
| Cell Line, Tumor | 11 | 2020 | 16905 | 0.150 |
Why?
|
| Cerebral Arteries | 1 | 2020 | 493 | 0.150 |
Why?
|
| Kidney | 6 | 2020 | 7072 | 0.150 |
Why?
|
| Lymphatic Vessels | 2 | 2020 | 358 | 0.150 |
Why?
|
| Female | 44 | 2024 | 391011 | 0.150 |
Why?
|
| Neurogenesis | 2 | 2015 | 855 | 0.150 |
Why?
|
| Colon | 2 | 2018 | 1788 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2009 | 4938 | 0.150 |
Why?
|
| Cell Aggregation | 1 | 1998 | 239 | 0.150 |
Why?
|
| Blotting, Northern | 8 | 2003 | 1544 | 0.150 |
Why?
|
| Receptors, Prostaglandin E, EP2 Subtype | 3 | 2007 | 49 | 0.140 |
Why?
|
| Neoplasms, Experimental | 2 | 2020 | 1229 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 3 | 2010 | 2696 | 0.140 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2020 | 485 | 0.140 |
Why?
|
| Luminescence | 1 | 2017 | 133 | 0.140 |
Why?
|
| Rats | 16 | 2007 | 23695 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 7 | 2011 | 2449 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 1 | 2018 | 513 | 0.140 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 3800 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2019 | 376 | 0.140 |
Why?
|
| Nephritis, Interstitial | 1 | 2018 | 154 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2007 | 2047 | 0.140 |
Why?
|
| Actins | 3 | 2018 | 2049 | 0.140 |
Why?
|
| Stem Cells | 1 | 2009 | 3525 | 0.140 |
Why?
|
| DNA | 6 | 2001 | 7236 | 0.130 |
Why?
|
| Endothelial Growth Factors | 3 | 2001 | 674 | 0.130 |
Why?
|
| Transduction, Genetic | 3 | 2008 | 897 | 0.130 |
Why?
|
| Tight Junctions | 2 | 2017 | 315 | 0.130 |
Why?
|
| Ureteral Obstruction | 2 | 2018 | 292 | 0.130 |
Why?
|
| G1 Phase | 3 | 2006 | 403 | 0.130 |
Why?
|
| TNF Receptor-Associated Factor 2 | 1 | 2015 | 57 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2019 | 580 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 15766 | 0.130 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 499 | 0.130 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2005 | 4494 | 0.130 |
Why?
|
| Thromboxanes | 2 | 2006 | 47 | 0.130 |
Why?
|
| Prostaglandins E | 1 | 1995 | 169 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 4 | 2012 | 88 | 0.130 |
Why?
|
| Colonic Neoplasms | 3 | 2014 | 2526 | 0.130 |
Why?
|
| Chlorambucil | 1 | 2015 | 42 | 0.130 |
Why?
|
| Protein Isoforms | 4 | 2018 | 1697 | 0.130 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2015 | 20 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2021 | 941 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2020 | 633 | 0.130 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 1262 | 0.120 |
Why?
|
| Oxidoreductases | 1 | 2017 | 412 | 0.120 |
Why?
|
| Myocytes, Cardiac | 1 | 2024 | 1656 | 0.120 |
Why?
|
| Research | 1 | 2004 | 1973 | 0.120 |
Why?
|
| Tristetraprolin | 1 | 2014 | 38 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 979 | 0.120 |
Why?
|
| Ischemic Attack, Transient | 1 | 2020 | 899 | 0.120 |
Why?
|
| Caspases | 2 | 2013 | 878 | 0.120 |
Why?
|
| Myelin Sheath | 1 | 2019 | 651 | 0.120 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2013 | 107 | 0.120 |
Why?
|
| Myelin Proteins | 1 | 2015 | 208 | 0.120 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1996 | 489 | 0.120 |
Why?
|
| Cell Cycle | 2 | 2000 | 2937 | 0.120 |
Why?
|
| Culture Media, Serum-Free | 4 | 2003 | 148 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2005 | 2804 | 0.120 |
Why?
|
| Oxadiazoles | 3 | 2018 | 94 | 0.120 |
Why?
|
| Chemokines, C | 1 | 2014 | 10 | 0.120 |
Why?
|
| Immunoprecipitation | 2 | 2008 | 877 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 6661 | 0.120 |
Why?
|
| Cricetulus | 2 | 2014 | 815 | 0.120 |
Why?
|
| Culture Media, Conditioned | 3 | 2006 | 522 | 0.120 |
Why?
|
| Pyridines | 6 | 2015 | 2877 | 0.120 |
Why?
|
| Myeloid Cells | 1 | 2019 | 821 | 0.120 |
Why?
|
| Cyclic AMP | 3 | 2009 | 1455 | 0.120 |
Why?
|
| Microscopy, Fluorescence | 3 | 2012 | 2651 | 0.120 |
Why?
|
| Genes, Lethal | 1 | 2014 | 225 | 0.120 |
Why?
|
| Oligonucleotides, Antisense | 4 | 2000 | 459 | 0.110 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2015 | 225 | 0.110 |
Why?
|
| Tissue Distribution | 3 | 2012 | 2262 | 0.110 |
Why?
|
| Male | 29 | 2024 | 359413 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 2015 | 251 | 0.110 |
Why?
|
| Cell Physiological Phenomena | 1 | 2015 | 150 | 0.110 |
Why?
|
| 3T3 Cells | 4 | 1999 | 1085 | 0.110 |
Why?
|
| Receptors, Fc | 1 | 2017 | 534 | 0.110 |
Why?
|
| Mutagenesis | 1 | 1998 | 1234 | 0.110 |
Why?
|
| Lymphokines | 2 | 2001 | 929 | 0.110 |
Why?
|
| Atrioventricular Node | 1 | 2014 | 180 | 0.110 |
Why?
|
| Sphingomyelins | 1 | 2014 | 103 | 0.110 |
Why?
|
| Cyclin D1 | 2 | 2008 | 453 | 0.110 |
Why?
|
| Adenoviridae | 2 | 2008 | 1084 | 0.110 |
Why?
|
| Antigen Presentation | 1 | 2019 | 1254 | 0.110 |
Why?
|
| Dexamethasone | 3 | 1999 | 1928 | 0.110 |
Why?
|
| Immunohistochemistry | 12 | 2014 | 11064 | 0.110 |
Why?
|
| Cycloheximide | 6 | 1997 | 343 | 0.110 |
Why?
|
| Epoprostenol | 4 | 1989 | 248 | 0.110 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 4355 | 0.110 |
Why?
|
| Laminin | 2 | 2005 | 405 | 0.110 |
Why?
|
| Aorta, Thoracic | 1 | 2019 | 1097 | 0.110 |
Why?
|
| Topotecan | 1 | 2013 | 132 | 0.110 |
Why?
|
| In Situ Hybridization | 2 | 2012 | 1900 | 0.110 |
Why?
|
| Receptors, LDL | 1 | 2015 | 491 | 0.110 |
Why?
|
| Embryonic Development | 2 | 2015 | 712 | 0.110 |
Why?
|
| Pseudopodia | 2 | 2020 | 168 | 0.110 |
Why?
|
| Topoisomerase I Inhibitors | 1 | 2013 | 74 | 0.110 |
Why?
|
| Virulence Factors, Bordetella | 4 | 2001 | 154 | 0.110 |
Why?
|
| GATA1 Transcription Factor | 1 | 2014 | 296 | 0.100 |
Why?
|
| Interleukin-6 | 3 | 2019 | 3207 | 0.100 |
Why?
|
| Immune System | 2 | 2011 | 795 | 0.100 |
Why?
|
| beta-Alanine | 1 | 2013 | 82 | 0.100 |
Why?
|
| Exons | 2 | 2014 | 2391 | 0.100 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 2368 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3804 | 0.100 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2012 | 82 | 0.100 |
Why?
|
| Phylogeny | 3 | 2005 | 2775 | 0.100 |
Why?
|
| Nitric Oxide | 2 | 2017 | 2141 | 0.100 |
Why?
|
| Hemorheology | 1 | 2012 | 144 | 0.100 |
Why?
|
| Protein Multimerization | 1 | 2017 | 983 | 0.100 |
Why?
|
| Protein Biosynthesis | 3 | 1997 | 2104 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2020 | 2003 | 0.100 |
Why?
|
| Pertussis Toxin | 3 | 2006 | 176 | 0.100 |
Why?
|
| Recombinant Proteins | 7 | 2005 | 6543 | 0.100 |
Why?
|
| GATA4 Transcription Factor | 1 | 2012 | 124 | 0.100 |
Why?
|
| Interleukin-17 | 2 | 2019 | 908 | 0.100 |
Why?
|
| Fatty Acids | 2 | 2017 | 1805 | 0.100 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 311 | 0.100 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2005 | 590 | 0.100 |
Why?
|
| Germinal Center | 1 | 2014 | 379 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2015 | 1128 | 0.100 |
Why?
|
| Proteoglycans | 2 | 2005 | 802 | 0.100 |
Why?
|
| Genome | 2 | 2012 | 1739 | 0.100 |
Why?
|
| RNA, Neoplasm | 1 | 2014 | 749 | 0.100 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 367 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2011 | 10829 | 0.090 |
Why?
|
| Apolipoproteins E | 3 | 2015 | 1437 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2009 | 2866 | 0.090 |
Why?
|
| Oocytes | 3 | 2001 | 1165 | 0.090 |
Why?
|
| Autoimmunity | 1 | 2019 | 1370 | 0.090 |
Why?
|
| Oxygen | 1 | 2022 | 4189 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 7 | 1997 | 6067 | 0.090 |
Why?
|
| Nuclear Proteins | 3 | 2010 | 5793 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2018 | 1007 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2017 | 8523 | 0.090 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 1083 | 0.090 |
Why?
|
| Thioglycolates | 1 | 2009 | 38 | 0.090 |
Why?
|
| RANK Ligand | 1 | 2012 | 318 | 0.090 |
Why?
|
| Suramin | 2 | 2000 | 34 | 0.090 |
Why?
|
| Transplantation, Heterologous | 3 | 2005 | 2378 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2010 | 149 | 0.090 |
Why?
|
| Disease | 2 | 2008 | 671 | 0.090 |
Why?
|
| Lipoproteins | 2 | 2015 | 882 | 0.090 |
Why?
|
| Time Factors | 11 | 2009 | 40133 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2011 | 419 | 0.090 |
Why?
|
| Terminology as Topic | 2 | 2010 | 1534 | 0.080 |
Why?
|
| RNA Stability | 2 | 2009 | 332 | 0.080 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2008 | 1655 | 0.080 |
Why?
|
| Protein Conformation | 3 | 2011 | 3969 | 0.080 |
Why?
|
| Cortactin | 2 | 2006 | 27 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 4357 | 0.080 |
Why?
|
| Stress, Mechanical | 2 | 2020 | 1666 | 0.080 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 279 | 0.080 |
Why?
|
| Anaphylaxis | 1 | 2016 | 753 | 0.080 |
Why?
|
| Cholesterol, HDL | 1 | 2015 | 1817 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 251 | 0.080 |
Why?
|
| Cytokines | 4 | 2018 | 7345 | 0.080 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2009 | 187 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 358 | 0.080 |
Why?
|
| Drug Combinations | 2 | 2005 | 2024 | 0.080 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2005 | 482 | 0.080 |
Why?
|
| Heart Rate | 2 | 2014 | 4169 | 0.080 |
Why?
|
| Gene Expression | 7 | 2006 | 7592 | 0.080 |
Why?
|
| Drug Resistance | 1 | 2014 | 1617 | 0.080 |
Why?
|
| Phenylhydrazines | 1 | 2008 | 28 | 0.080 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2009 | 143 | 0.080 |
Why?
|
| Body Patterning | 1 | 2012 | 630 | 0.080 |
Why?
|
| Phospholipase C beta | 1 | 2008 | 49 | 0.080 |
Why?
|
| Sulfonamides | 3 | 2007 | 1973 | 0.080 |
Why?
|
| Endotoxins | 1 | 2010 | 521 | 0.080 |
Why?
|
| Receptor, erbB-2 | 3 | 2013 | 2544 | 0.080 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 623 | 0.080 |
Why?
|
| Luciferases | 3 | 2017 | 716 | 0.080 |
Why?
|
| Mice, 129 Strain | 2 | 2020 | 373 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2015 | 895 | 0.080 |
Why?
|
| Paracrine Communication | 1 | 2009 | 278 | 0.070 |
Why?
|
| Receptors, CXCR4 | 1 | 2012 | 728 | 0.070 |
Why?
|
| Kidney Neoplasms | 3 | 2009 | 4312 | 0.070 |
Why?
|
| Triglycerides | 1 | 2015 | 2476 | 0.070 |
Why?
|
| Cell Nucleus | 6 | 2000 | 2909 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1997 | 2823 | 0.070 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 789 | 0.070 |
Why?
|
| Neoplasm Transplantation | 2 | 2004 | 2014 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 1799 | 0.070 |
Why?
|
| Leukopenia | 1 | 2008 | 212 | 0.070 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2008 | 144 | 0.070 |
Why?
|
| Diet | 1 | 2005 | 8008 | 0.070 |
Why?
|
| Stress Fibers | 1 | 2007 | 55 | 0.070 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2007 | 123 | 0.070 |
Why?
|
| Radiation Tolerance | 1 | 2009 | 480 | 0.070 |
Why?
|
| Stria Vascularis | 1 | 2007 | 30 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2009 | 368 | 0.070 |
Why?
|
| Leupeptins | 1 | 2007 | 113 | 0.070 |
Why?
|
| Whole-Body Irradiation | 1 | 2008 | 433 | 0.070 |
Why?
|
| Nucleic Acid Hybridization | 4 | 1994 | 1304 | 0.070 |
Why?
|
| Transplantation Chimera | 1 | 2009 | 595 | 0.070 |
Why?
|
| Half-Life | 1 | 2008 | 652 | 0.070 |
Why?
|
| Genetic Vectors | 2 | 2008 | 3378 | 0.070 |
Why?
|
| Ki-67 Antigen | 1 | 2008 | 631 | 0.070 |
Why?
|
| Luminescent Proteins | 2 | 1999 | 835 | 0.070 |
Why?
|
| Rectal Neoplasms | 1 | 1995 | 1151 | 0.070 |
Why?
|
| Anemia, Sickle Cell | 1 | 2015 | 1056 | 0.070 |
Why?
|
| HCT116 Cells | 1 | 2007 | 402 | 0.070 |
Why?
|
| Salivary Glands | 1 | 2008 | 229 | 0.070 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2006 | 221 | 0.070 |
Why?
|
| Ubiquitination | 1 | 2011 | 1010 | 0.070 |
Why?
|
| Microcirculation | 2 | 2021 | 1279 | 0.070 |
Why?
|
| Collagen | 2 | 2005 | 2635 | 0.070 |
Why?
|
| Calcium | 5 | 2006 | 5726 | 0.070 |
Why?
|
| Protein Kinase C-alpha | 1 | 2006 | 113 | 0.070 |
Why?
|
| Chromans | 3 | 2001 | 117 | 0.070 |
Why?
|
| Chordata | 1 | 2005 | 6 | 0.070 |
Why?
|
| Sjogren's Syndrome | 1 | 2008 | 235 | 0.070 |
Why?
|
| Food Coloring Agents | 1 | 2005 | 7 | 0.070 |
Why?
|
| Ciona intestinalis | 1 | 2005 | 10 | 0.070 |
Why?
|
| Bacteriorhodopsins | 1 | 2005 | 13 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2015 | 2422 | 0.070 |
Why?
|
| Skin | 2 | 2018 | 4468 | 0.060 |
Why?
|
| Endothelium | 3 | 2024 | 764 | 0.060 |
Why?
|
| Tyrosine | 2 | 2005 | 1440 | 0.060 |
Why?
|
| COS Cells | 2 | 2015 | 1129 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2214 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 1737 | 0.060 |
Why?
|
| Inbreeding | 1 | 2005 | 48 | 0.060 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2007 | 253 | 0.060 |
Why?
|
| Breast Neoplasms | 5 | 2007 | 21065 | 0.060 |
Why?
|
| Chemokines | 1 | 2009 | 962 | 0.060 |
Why?
|
| Intracellular Space | 1 | 2006 | 197 | 0.060 |
Why?
|
| Genes, Dominant | 3 | 2008 | 863 | 0.060 |
Why?
|
| Nervous System | 1 | 2008 | 543 | 0.060 |
Why?
|
| S Phase | 1 | 2006 | 422 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2003 | 2178 | 0.060 |
Why?
|
| Leukotrienes | 2 | 2004 | 234 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2716 | 0.060 |
Why?
|
| Tamoxifen | 1 | 2009 | 963 | 0.060 |
Why?
|
| Anthozoa | 1 | 2005 | 65 | 0.060 |
Why?
|
| Cell Hypoxia | 1 | 2007 | 657 | 0.060 |
Why?
|
| Blotting, Southern | 2 | 1996 | 778 | 0.060 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2011 | 1977 | 0.060 |
Why?
|
| Germ Cells | 1 | 2009 | 635 | 0.060 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1994 | 1870 | 0.060 |
Why?
|
| Interleukin-1beta | 1 | 2010 | 999 | 0.060 |
Why?
|
| Adipocytes | 2 | 2011 | 1179 | 0.060 |
Why?
|
| Copper | 1 | 2007 | 368 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2014 | 1553 | 0.060 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2005 | 107 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2006 | 565 | 0.060 |
Why?
|
| Galactosidases | 1 | 2004 | 55 | 0.060 |
Why?
|
| Heparin | 1 | 1991 | 1655 | 0.060 |
Why?
|
| Mitogens | 2 | 2003 | 230 | 0.060 |
Why?
|
| Organic Chemicals | 1 | 2005 | 211 | 0.060 |
Why?
|
| Cell Growth Processes | 3 | 2014 | 384 | 0.060 |
Why?
|
| Reproduction | 1 | 2008 | 647 | 0.060 |
Why?
|
| Invertebrates | 1 | 2004 | 54 | 0.060 |
Why?
|
| Genitalia | 1 | 2004 | 113 | 0.060 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 563 | 0.060 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2004 | 114 | 0.060 |
Why?
|
| Plasma | 1 | 2007 | 584 | 0.060 |
Why?
|
| Hematopoiesis | 2 | 2012 | 2063 | 0.060 |
Why?
|
| Drug Antagonism | 1 | 2003 | 51 | 0.060 |
Why?
|
| Mitochondria | 1 | 2017 | 3598 | 0.060 |
Why?
|
| Transcriptional Activation | 2 | 2007 | 1755 | 0.060 |
Why?
|
| Platelet Activating Factor | 1 | 2004 | 143 | 0.060 |
Why?
|
| Catalase | 1 | 2004 | 216 | 0.060 |
Why?
|
| Influenza, Human | 1 | 2015 | 1532 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2007 | 1549 | 0.060 |
Why?
|
| Serotonin | 1 | 2008 | 1041 | 0.060 |
Why?
|
| Molecular Probes | 1 | 2005 | 313 | 0.060 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 732 | 0.060 |
Why?
|
| Chromatography, Liquid | 2 | 2005 | 987 | 0.060 |
Why?
|
| Gastrointestinal Tract | 1 | 2009 | 830 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2005 | 2755 | 0.050 |
Why?
|
| Paroxetine | 1 | 2024 | 182 | 0.050 |
Why?
|
| Thiazoles | 5 | 2002 | 1509 | 0.050 |
Why?
|
| Histocytochemistry | 1 | 2004 | 693 | 0.050 |
Why?
|
| Deafness | 1 | 2007 | 456 | 0.050 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 688 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2003 | 267 | 0.050 |
Why?
|
| Plants | 1 | 2004 | 318 | 0.050 |
Why?
|
| Chemotactic Factors | 1 | 2003 | 196 | 0.050 |
Why?
|
| Melanoma, Experimental | 1 | 2006 | 562 | 0.050 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2018 | 613 | 0.050 |
Why?
|
| Protein Kinase C | 3 | 2009 | 1201 | 0.050 |
Why?
|
| STAT3 Transcription Factor | 2 | 2019 | 877 | 0.050 |
Why?
|
| Connective Tissue Growth Factor | 2 | 2015 | 91 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2004 | 614 | 0.050 |
Why?
|
| Hyperplasia | 1 | 2005 | 1158 | 0.050 |
Why?
|
| Carcinoma, Small Cell | 2 | 2001 | 416 | 0.050 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2014 | 975 | 0.050 |
Why?
|
| Monocytes | 2 | 2019 | 2574 | 0.050 |
Why?
|
| Symporters | 1 | 2004 | 361 | 0.050 |
Why?
|
| Photons | 1 | 2005 | 581 | 0.050 |
Why?
|
| Synovial Fluid | 2 | 2012 | 395 | 0.050 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 1890 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2001 | 94 | 0.050 |
Why?
|
| Phenotype | 3 | 2022 | 16543 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2005 | 478 | 0.050 |
Why?
|
| Aging | 1 | 2020 | 8641 | 0.050 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2001 | 203 | 0.050 |
Why?
|
| Fungi | 1 | 2004 | 338 | 0.050 |
Why?
|
| Arthritis | 2 | 2000 | 666 | 0.050 |
Why?
|
| Rats, Wistar | 2 | 2002 | 1849 | 0.050 |
Why?
|
| BRCA1 Protein | 1 | 2007 | 1146 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4739 | 0.050 |
Why?
|
| Glycocalyx | 1 | 2021 | 94 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2007 | 1972 | 0.050 |
Why?
|
| Arachidonic Acid | 2 | 2001 | 434 | 0.050 |
Why?
|
| Enzyme Induction | 3 | 2004 | 452 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 112 | 0.050 |
Why?
|
| Neoplasm Metastasis | 1 | 2011 | 4891 | 0.050 |
Why?
|
| Bromodeoxyuridine | 1 | 2000 | 310 | 0.040 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2001 | 180 | 0.040 |
Why?
|
| Microbodies | 1 | 2000 | 36 | 0.040 |
Why?
|
| Epoxy Compounds | 1 | 2000 | 136 | 0.040 |
Why?
|
| Auranofin | 1 | 1999 | 16 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1992 | 778 | 0.040 |
Why?
|
| Th17 Cells | 2 | 2019 | 789 | 0.040 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2024 | 619 | 0.040 |
Why?
|
| Thrombocytopenia | 1 | 2008 | 1174 | 0.040 |
Why?
|
| Aspirin | 3 | 1989 | 3365 | 0.040 |
Why?
|
| Aequorin | 1 | 1999 | 15 | 0.040 |
Why?
|
| RNA Transport | 1 | 2019 | 45 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2005 | 1346 | 0.040 |
Why?
|
| Prostaglandins A | 1 | 1999 | 13 | 0.040 |
Why?
|
| Embryo, Nonmammalian | 2 | 2014 | 899 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2015 | 730 | 0.040 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 1711 | 0.040 |
Why?
|
| Species Specificity | 1 | 2004 | 2413 | 0.040 |
Why?
|
| Mucins | 1 | 2003 | 568 | 0.040 |
Why?
|
| Epidermal Growth Factor | 3 | 1989 | 695 | 0.040 |
Why?
|
| Light | 1 | 2005 | 1344 | 0.040 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2003 | 475 | 0.040 |
Why?
|
| Thymus Gland | 1 | 2004 | 1246 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 4 | 2004 | 5784 | 0.040 |
Why?
|
| Arthus Reaction | 1 | 2018 | 14 | 0.040 |
Why?
|
| Platelet Activation | 1 | 2003 | 661 | 0.040 |
Why?
|
| Brain | 3 | 2017 | 26912 | 0.040 |
Why?
|
| Peroxidases | 1 | 1999 | 135 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2009 | 2927 | 0.040 |
Why?
|
| Albumins | 1 | 2021 | 577 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2004 | 1955 | 0.040 |
Why?
|
| GTPase-Activating Proteins | 1 | 2022 | 475 | 0.040 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2002 | 675 | 0.040 |
Why?
|
| beta Catenin | 1 | 2024 | 1043 | 0.040 |
Why?
|
| Indomethacin | 2 | 1992 | 326 | 0.040 |
Why?
|
| Biological Evolution | 1 | 2004 | 1074 | 0.040 |
Why?
|
| Myosin Light Chains | 1 | 2018 | 121 | 0.040 |
Why?
|
| History, 20th Century | 1 | 2006 | 2777 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1999 | 385 | 0.040 |
Why?
|
| Cytosol | 1 | 2001 | 887 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 2 | 2011 | 124 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 749 | 0.040 |
Why?
|
| Histones | 1 | 2008 | 2583 | 0.040 |
Why?
|
| Anemia | 1 | 2008 | 1511 | 0.040 |
Why?
|
| Glycolipids | 1 | 2019 | 204 | 0.040 |
Why?
|
| Indans | 1 | 2018 | 91 | 0.040 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2022 | 568 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1999 | 532 | 0.040 |
Why?
|
| Thrombosis | 1 | 2012 | 3052 | 0.040 |
Why?
|
| Cardiac Myosins | 1 | 2018 | 124 | 0.040 |
Why?
|
| Fibrin | 1 | 2001 | 505 | 0.040 |
Why?
|
| RNA, Untranslated | 1 | 2001 | 459 | 0.040 |
Why?
|
| Bacterial Toxins | 2 | 1995 | 931 | 0.040 |
Why?
|
| Adenocarcinoma | 1 | 1995 | 6310 | 0.040 |
Why?
|
| Thionucleotides | 1 | 1997 | 112 | 0.040 |
Why?
|
| Jurkat Cells | 1 | 1999 | 736 | 0.040 |
Why?
|
| Vascular Patency | 1 | 2020 | 901 | 0.040 |
Why?
|
| Joints | 1 | 2019 | 321 | 0.040 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2005 | 1094 | 0.040 |
Why?
|
| RNA | 2 | 2021 | 2721 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2005 | 2208 | 0.040 |
Why?
|
| GTP Phosphohydrolases | 1 | 2001 | 516 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2006 | 2441 | 0.040 |
Why?
|
| Feedback | 1 | 2001 | 791 | 0.040 |
Why?
|
| Immunity | 1 | 2003 | 998 | 0.040 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 1996 | 16 | 0.040 |
Why?
|
| Peyer's Patches | 1 | 2017 | 120 | 0.040 |
Why?
|
| Electrophoresis | 1 | 1997 | 234 | 0.040 |
Why?
|
| Genetic Complementation Test | 1 | 2017 | 555 | 0.030 |
Why?
|
| Homozygote | 2 | 2017 | 1786 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 22041 | 0.030 |
Why?
|
| Ribonuclease H | 1 | 1996 | 50 | 0.030 |
Why?
|
| Drug Synergism | 3 | 2013 | 1755 | 0.030 |
Why?
|
| Sequence Tagged Sites | 1 | 1996 | 94 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2019 | 694 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 1998 | 2282 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2017 | 428 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2019 | 1649 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2014 | 5644 | 0.030 |
Why?
|
| Proteomics | 2 | 2007 | 3810 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 1996 | 197 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2671 | 0.030 |
Why?
|
| Osteoarthritis | 4 | 2006 | 1055 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1999 | 1230 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 1997 | 251 | 0.030 |
Why?
|
| Poly A | 1 | 1996 | 181 | 0.030 |
Why?
|
| Anilides | 1 | 2018 | 409 | 0.030 |
Why?
|
| Phospholipases A | 1 | 1996 | 204 | 0.030 |
Why?
|
| Lung Neoplasms | 4 | 2001 | 13249 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7268 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 1999 | 964 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1998 | 1746 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 1996 | 240 | 0.030 |
Why?
|
| Pregnancy | 2 | 2008 | 29725 | 0.030 |
Why?
|
| NIH 3T3 Cells | 2 | 2007 | 670 | 0.030 |
Why?
|
| Rats, Inbred Lew | 4 | 2000 | 1154 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2006 | 3448 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2018 | 553 | 0.030 |
Why?
|
| Spleen | 2 | 2017 | 2298 | 0.030 |
Why?
|
| Autoantigens | 1 | 2019 | 877 | 0.030 |
Why?
|
| Genomic Library | 1 | 1994 | 189 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2014 | 72 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1168 | 0.030 |
Why?
|
| Mutation | 5 | 2015 | 29950 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2004 | 3442 | 0.030 |
Why?
|
| Adjuvants, Immunologic | 1 | 2000 | 1041 | 0.030 |
Why?
|
| Sirolimus | 1 | 2001 | 1548 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1663 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2003 | 4573 | 0.030 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 2 | 2007 | 87 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 191 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1996 | 565 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 852 | 0.030 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 961 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 828 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 1998 | 1531 | 0.030 |
Why?
|
| Neutrophils | 1 | 2006 | 3770 | 0.030 |
Why?
|
| Lymphocyte Activation | 3 | 2014 | 5498 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1493 | 0.030 |
Why?
|
| Dendritic Cells | 2 | 2019 | 2730 | 0.030 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1614 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1994 | 815 | 0.030 |
Why?
|
| Hepatocytes | 1 | 2020 | 1228 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1990 | 418 | 0.030 |
Why?
|
| Binding Sites | 3 | 2014 | 6050 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2001 | 5248 | 0.030 |
Why?
|
| Gastrulation | 1 | 2012 | 33 | 0.030 |
Why?
|
| Cell Death | 2 | 2013 | 1670 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 17766 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2013 | 250 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2001 | 2414 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1990 | 1056 | 0.030 |
Why?
|
| Cattle | 3 | 2001 | 3847 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2014 | 750 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 2702 | 0.030 |
Why?
|
| Liver | 1 | 2008 | 7512 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 2 | 1989 | 214 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2019 | 1483 | 0.020 |
Why?
|
| Cricetinae | 2 | 2006 | 2427 | 0.020 |
Why?
|
| ADP Ribose Transferases | 1 | 1991 | 90 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2000 | 1884 | 0.020 |
Why?
|
| Exotoxins | 1 | 1991 | 121 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2006 | 9283 | 0.020 |
Why?
|
| Myocardium | 1 | 2004 | 4688 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 1994 | 1993 | 0.020 |
Why?
|
| Cytotoxins | 1 | 1991 | 153 | 0.020 |
Why?
|
| Ibuprofen | 1 | 1992 | 229 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 9196 | 0.020 |
Why?
|
| Heterozygote | 1 | 2017 | 2797 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2001 | 2978 | 0.020 |
Why?
|
| Colonoscopy | 1 | 2018 | 1387 | 0.020 |
Why?
|
| Cerebrovascular Circulation | 1 | 2020 | 2731 | 0.020 |
Why?
|
| Forecasting | 1 | 1999 | 2931 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 613 | 0.020 |
Why?
|
| Glioblastoma | 1 | 2005 | 3482 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 8984 | 0.020 |
Why?
|
| Autopsy | 1 | 2013 | 1007 | 0.020 |
Why?
|
| Cytoplasm | 2 | 2005 | 1518 | 0.020 |
Why?
|
| Epitopes | 1 | 1996 | 2506 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 1996 | 2143 | 0.020 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2009 | 37 | 0.020 |
Why?
|
| Thymidine | 1 | 1989 | 299 | 0.020 |
Why?
|
| Arthritis, Infectious | 1 | 1993 | 345 | 0.020 |
Why?
|
| Middle Aged | 7 | 2014 | 220175 | 0.020 |
Why?
|
| Phospholipase D | 1 | 2009 | 67 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5873 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 203 | 0.020 |
Why?
|
| Diglycerides | 1 | 2009 | 176 | 0.020 |
Why?
|
| Microvessels | 1 | 2013 | 572 | 0.020 |
Why?
|
| Obesity | 1 | 2011 | 12915 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 2008 | 190 | 0.020 |
Why?
|
| Gestational Age | 1 | 1997 | 3564 | 0.020 |
Why?
|
| Aged | 5 | 2014 | 168995 | 0.020 |
Why?
|
| Models, Molecular | 2 | 2011 | 5429 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2004 | 8058 | 0.020 |
Why?
|
| Receptors, Prostaglandin E, EP4 Subtype | 1 | 2007 | 44 | 0.020 |
Why?
|
| Virulence Factors | 1 | 1991 | 508 | 0.020 |
Why?
|
| Sheep | 2 | 1990 | 1441 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2012 | 1617 | 0.020 |
Why?
|
| Globins | 1 | 1988 | 403 | 0.020 |
Why?
|
| Molybdenum | 1 | 2007 | 46 | 0.020 |
Why?
|
| Psoriasis | 1 | 2015 | 939 | 0.020 |
Why?
|
| Gene Library | 1 | 1990 | 1060 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1986 | 119 | 0.020 |
Why?
|
| Growth Substances | 1 | 1989 | 768 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 444 | 0.020 |
Why?
|
| Protein Kinase C-epsilon | 1 | 2006 | 43 | 0.020 |
Why?
|
| Disease Progression | 1 | 2003 | 13505 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2003 | 4875 | 0.020 |
Why?
|
| Seminal Vesicles | 1 | 1986 | 107 | 0.020 |
Why?
|
| Biopsy | 1 | 2018 | 6775 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 1979 | 0.020 |
Why?
|
| Alleles | 1 | 2017 | 6900 | 0.020 |
Why?
|
| Cholesterol | 1 | 2015 | 2925 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 413 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 616 | 0.020 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1520 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 1989 | 755 | 0.020 |
Why?
|
| Chelating Agents | 1 | 2007 | 384 | 0.020 |
Why?
|
| Ribonucleoproteins | 1 | 1988 | 372 | 0.020 |
Why?
|
| Chloroquine | 1 | 2007 | 277 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1989 | 1135 | 0.020 |
Why?
|
| Epithelial Cells | 2 | 2008 | 3665 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2006 | 290 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2013 | 3584 | 0.020 |
Why?
|
| Amyloid | 1 | 1989 | 843 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1395 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2018 | 2421 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 474 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1760 | 0.010 |
Why?
|
| Pseudomonas aeruginosa | 1 | 1991 | 1275 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1988 | 914 | 0.010 |
Why?
|
| Phthalazines | 1 | 2006 | 377 | 0.010 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2001 | 666 | 0.010 |
Why?
|
| CHO Cells | 1 | 2006 | 1389 | 0.010 |
Why?
|
| Tumor Necrosis Factors | 1 | 2003 | 106 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2006 | 544 | 0.010 |
Why?
|
| Retinoid X Receptors | 1 | 2002 | 91 | 0.010 |
Why?
|
| Amides | 1 | 2005 | 448 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9388 | 0.010 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1985 | 412 | 0.010 |
Why?
|
| Tunica Media | 1 | 2002 | 112 | 0.010 |
Why?
|
| Aromatase Inhibitors | 1 | 2006 | 511 | 0.010 |
Why?
|
| Epithelium | 1 | 2007 | 1605 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2008 | 1536 | 0.010 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2002 | 224 | 0.010 |
Why?
|
| Colony-Stimulating Factors | 1 | 2002 | 218 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2003 | 282 | 0.010 |
Why?
|
| International Agencies | 1 | 2002 | 244 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5640 | 0.010 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 521 | 0.010 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2003 | 280 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2004 | 1032 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2005 | 12156 | 0.010 |
Why?
|
| Leukotriene Antagonists | 1 | 2001 | 124 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 3618 | 0.010 |
Why?
|
| Temperature | 1 | 2007 | 2221 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2003 | 584 | 0.010 |
Why?
|
| Chromium Radioisotopes | 1 | 1999 | 34 | 0.010 |
Why?
|
| Rabbits | 1 | 1986 | 4773 | 0.010 |
Why?
|
| Tunica Intima | 1 | 2002 | 459 | 0.010 |
Why?
|
| Sulfur Radioisotopes | 1 | 1999 | 113 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2000 | 366 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 7400 | 0.010 |
Why?
|
| Fibroblast Growth Factors | 1 | 2006 | 867 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 2000 | 337 | 0.010 |
Why?
|
| Heart Failure | 1 | 2024 | 11835 | 0.010 |
Why?
|
| Spodoptera | 1 | 1999 | 141 | 0.010 |
Why?
|
| Binding, Competitive | 2 | 1991 | 1143 | 0.010 |
Why?
|
| Immune Sera | 1 | 2000 | 613 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3160 | 0.010 |
Why?
|
| Biology | 1 | 2001 | 289 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2003 | 1340 | 0.010 |
Why?
|
| Culture Media | 1 | 2001 | 899 | 0.010 |
Why?
|
| United States | 1 | 2006 | 72363 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2192 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 2002 | 752 | 0.010 |
Why?
|
| PC12 Cells | 1 | 1998 | 317 | 0.010 |
Why?
|
| Cornea | 1 | 2006 | 1325 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 908 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 1998 | 363 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2003 | 1135 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2000 | 11341 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 1433 | 0.010 |
Why?
|
| Ankle | 1 | 2000 | 350 | 0.010 |
Why?
|
| Cysteine | 1 | 2001 | 897 | 0.010 |
Why?
|
| Clone Cells | 1 | 2000 | 1663 | 0.010 |
Why?
|
| Prostatic Hyperplasia | 1 | 2000 | 531 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 12602 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2003 | 1828 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2001 | 1745 | 0.010 |
Why?
|
| Adult | 4 | 2008 | 219847 | 0.010 |
Why?
|
| Benzhydryl Compounds | 1 | 2000 | 942 | 0.010 |
Why?
|
| Prognosis | 2 | 2005 | 29636 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2000 | 1890 | 0.010 |
Why?
|
| Rats, Nude | 1 | 1992 | 105 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 1993 | 456 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 1993 | 825 | 0.010 |
Why?
|
| Streptococcus | 1 | 1992 | 198 | 0.010 |
Why?
|
| Genes, Synthetic | 1 | 1991 | 88 | 0.010 |
Why?
|
| Infant | 1 | 2013 | 36030 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 1991 | 191 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 2218 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 4546 | 0.010 |
Why?
|
| Receptors, Mitogen | 1 | 1990 | 61 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2003 | 10185 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 42034 | 0.010 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1990 | 224 | 0.010 |
Why?
|
| Genomics | 1 | 2005 | 5790 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6226 | 0.010 |
Why?
|
| Cell Wall | 1 | 1992 | 425 | 0.000 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 1988 | 75 | 0.000 |
Why?
|
| Templates, Genetic | 1 | 1988 | 189 | 0.000 |
Why?
|
| RNA, Small Nuclear | 1 | 1988 | 74 | 0.000 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 58947 | 0.000 |
Why?
|
| RNA Precursors | 1 | 1988 | 212 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1991 | 1090 | 0.000 |
Why?
|
| Molecular Structure | 1 | 1990 | 1895 | 0.000 |
Why?
|
| Child | 1 | 2013 | 79758 | 0.000 |
Why?
|
| Genes | 1 | 1988 | 1845 | 0.000 |
Why?
|
| Arachidonic Acids | 1 | 1985 | 294 | 0.000 |
Why?
|
| Autoradiography | 1 | 1985 | 730 | 0.000 |
Why?
|
| Plasmids | 1 | 1989 | 2277 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1990 | 3086 | 0.000 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 1989 | 1110 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1985 | 2094 | 0.000 |
Why?
|
| DNA Replication | 1 | 1990 | 1412 | 0.000 |
Why?
|
| Knee Joint | 1 | 1992 | 1662 | 0.000 |
Why?
|
| Colorectal Neoplasms | 1 | 2003 | 6855 | 0.000 |
Why?
|
| Blood | 1 | 1985 | 586 | 0.000 |
Why?
|
| HeLa Cells | 1 | 1988 | 3105 | 0.000 |
Why?
|
| Adolescent | 1 | 2003 | 87747 | 0.000 |
Why?
|